Cargando…

The cyclin dependent kinase inhibitor p21(Cip1/Waf1) is a therapeutic target in high-risk neuroblastoma

Platinum-based chemotherapies such as cisplatin are used as first-line treatment for the paediatric tumour neuroblastoma. Although the majority of neuroblastoma tumours respond to therapy, there is a high fraction of high-risk neuroblastoma patients that eventually relapse with increased resistance....

Descripción completa

Detalles Bibliográficos
Autores principales: Sorteberg, Agnes Luise, Halipi, Vesa, Wickström, Malin, Shirazi Fard, Shahrzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486206/
https://www.ncbi.nlm.nih.gov/pubmed/36147919
http://dx.doi.org/10.3389/fonc.2022.906194